Y-mAbs Therapeutics, Inc. financial data

Symbol
YMAB on Nasdaq
Location
202 Carnegie Center, Suite 301, Princeton, NJ
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 8, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 418 % -6.63%
Quick Ratio 37.9 % +34.2%
Debt-to-equity 30.2 % -6.87%
Return On Equity -24.6 % +1.17%
Return On Assets -18.9 % -0.53%
Operating Margin -31.2 % +2.29%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 45.4M shares +1.95%
Common Stock, Shares, Outstanding 45.4M shares +1.96%
Entity Public Float 450M USD +82.9%
Common Stock, Value, Issued 5K USD +25%
Weighted Average Number of Shares Outstanding, Basic 45.3M shares +2.94%
Weighted Average Number of Shares Outstanding, Diluted 45.3M shares +2.94%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 85.4M USD -1.34%
Research and Development Expense 45.8M USD -15.7%
Costs and Expenses 96.5M USD -1.26%
Operating Income (Loss) -26.7M USD +3.6%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -22.6M USD +5.65%
Income Tax Expense (Benefit) -394K USD -161%
Net Income (Loss) Attributable to Parent -22.2M USD +9.71%
Earnings Per Share, Basic 0 USD/shares +10.7%
Earnings Per Share, Diluted 0 USD/shares +10.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 62.3M USD -19.9%
Accounts Receivable, after Allowance for Credit Loss, Current 15.7M USD -29.1%
Inventory, Net 9.72M USD +14.4%
Other Assets, Current 4.04M USD +79.9%
Assets, Current 91.8M USD -27.6%
Property, Plant and Equipment, Net 269K USD +209%
Operating Lease, Right-of-Use Asset 3.11M USD +145%
Intangible Assets, Net (Excluding Goodwill) 2.18M USD -11.3%
Other Assets, Noncurrent 646K USD -95.2%
Assets 117M USD -18.6%
Accounts Payable, Current 7.57M USD -25.7%
Accrued Liabilities, Current 14.9M USD +16.4%
Liabilities, Current 22.9M USD -47.2%
Operating Lease, Liability, Noncurrent 2.64M USD +511%
Other Liabilities, Noncurrent 935K USD +10.4%
Liabilities 29.7M USD -39%
Accumulated Other Comprehensive Income (Loss), Net of Tax -612K USD -158%
Retained Earnings (Accumulated Deficit) -496M USD -4.7%
Stockholders' Equity Attributable to Parent 87.5M USD -8.23%
Liabilities and Equity 117M USD -18.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -6.91M USD -98.8%
Net Cash Provided by (Used in) Financing Activities 114K USD -80.6%
Net Cash Provided by (Used in) Investing Activities -127K USD
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 45.4M shares +1.96%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -6.92M USD -140%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 62.3M USD -19.9%
Deferred Tax Assets, Valuation Allowance 151M USD +1.5%
Operating Lease, Liability 3.12M USD +145%
Payments to Acquire Property, Plant, and Equipment 127K USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -23.9M USD +2.95%
Lessee, Operating Lease, Liability, to be Paid 4.45M USD +223%
Operating Lease, Liability, Current 486K USD -42.3%
Lessee, Operating Lease, Liability, to be Paid, Year Two 382K USD +104%
Lessee, Operating Lease, Liability, to be Paid, Year One 533K USD -21.7%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure -11.8%
Deferred Income Tax Expense (Benefit) 0 USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.32M USD +1209%
Lessee, Operating Lease, Liability, to be Paid, Year Three 372K USD +2225%
Deferred Tax Assets, Operating Loss Carryforwards 83.2M USD -0.01%
Preferred Stock, Shares Issued 0 shares
Current Income Tax Expense (Benefit) -394K USD -93%
Preferred Stock, Shares Authorized 5.5M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 377K USD
Operating Lease, Payments 982K USD -6.39%
Additional Paid in Capital 584M USD +2.83%
Depreciation, Depletion and Amortization 71K USD -55.3%
Share-based Payment Arrangement, Expense 13.5M USD +5.45%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%